Key terms
About ADIL
Adial Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment or prevention of addiction and related disorders. It offers the AD04, a selective serotonin-3 antagonist. The company was founded by Bankole A. Johnson and William B. Stilley, III in November 2010 and is headquartered in Glen Allen, VA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest ADIL news
Apr 22
8:41am ET
Adial Pharmaceuticals granted key patent from USPTO
Apr 16
4:52pm ET
Adial Pharmaceuticals Announces CMO’s Departure and Leadership Changes
Apr 12
4:26pm ET
Adial Pharmaceuticals files to sell 2.37M shares of common stock for holders
Apr 12
11:08am ET
Biotech Alert: Searches spiking for these stocks today
Apr 03
2:02am ET
Adial Pharma’s Cybersecurity Challenge: Navigating the Risks of IT Dependence in Data Management
Mar 04
10:50am ET
Biotech Alert: Searches spiking for these stocks today
Mar 01
11:04am ET
Biotech Alert: Searches spiking for these stocks today
Feb 28
9:30am ET
Adial Pharmaceuticals awarded new patent from USPTO
Feb 26
8:30am ET
Two new option listings and option delistings on February 26th
Feb 16
11:22am ET
Biotech Alert: Searches spiking for these stocks today
Feb 15
11:05am ET
Biotech Alert: Searches spiking for these stocks today
Feb 14
1:22pm ET
Adial sees patent award boosting partnering efforts, says Brookline
No recent press releases are available for ADIL
ADIL Financials
Key terms
Ad Feedback
ADIL Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
ADIL Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
